Featured Articles

  1. Why 'Be Your Authentic Self' Is Actually Bad Advice 1/23/2026

    Raw authenticity can be disruptive in life sciences workplaces, but learning corporate fluency and stylistic pivots can help leaders become strategically authentic, writes Hope Mueller.

  2. A Serial Biotech Entrepreneur's Recipe For Success 1/21/2026

    Pushing boundaries, staying grounded, and having fun along the way are the key ingredients for success in biotech, writes Nuvation Bio Founder, President, and CEO David Hung, M.D.

  3. From Lab To Launch: Navigating The Transition To Commercial Readiness 1/13/2026

    Many clinical-stage companies start thinking about commercialization too late. FTI Consulting experts team up to provide guidance on getting started early.

  4. Visibility Without Discoverability: A Life Sciences Marketing Challenge 1/9/2026

    Life sciences organizations are highly visible and active across established media channels, but discoverability represents an area of untapped potential, writes Daan Inghelram.

  5. Building Biotech's Future: The Strategic Imperative Of AI Integration 1/6/2026

    Biotech companies that will lead the next decade won't just have better science, they'll have superior operating models, writes Samina Bari.

  6. FDA Further Expands And Clarifies Expanded Access FAQs 12/29/2025

    Healthcare attorney Dianne J. Bourque breaks down the FDA's October 2025 update to its Expanded Access FAQs.

  7. Your Microbiome Might Be Trying To Tell You Something 12/22/2025

    Burnout is not an individual failure: it’s a systems imbalance, biologically and organizationally, write Tony Martignetti and Adela Bonoiu, Ph.D. 

  8. 2025's Top 5 Drug Discovery Highlights And How To Stay Ahead In 2026 12/15/2025

    Drug Discovery Online's 2025 Top 5 most consequential shifts affecting this rapidly evolving field, including NAMs, AI, Individualized Therapies, Innovating China, and Early-stage Funding Volatility.

  9. There's A Big Misconception Around 'Inclusion,' And It's Holding Us Back 12/10/2025

    Inclusion is bigger than policy or workplace acronyms. It’s a way of living and fostering greater outcomes, writes Novo Nordisk's Jill Fallows Macaluso.

  10. Biotech Wasn't Ready For AI's Speed; Here's How We Catch Up 12/5/2025

    Computational success is no stand-in for therapeutic readiness. Innovators must learn to discern between models rooted in science and those that speculate.